Please login to the form below

Ensuring quality in medical translation when working ‘blind’

Working with people and not relying on inflexible systems is crucial
The quality systems that we work to, such as GMP or GCP, provide control in our work that directly improves the lives of many people, within which, patients’ safety is fundamental. However, with clinical trials increasingly run on an international basis, involving many different territories simultaneously, how do clinical trial administrators ensure the quality of the translations that they are responsible for without the specific knowledge of the target languages? In other words, when working ‘blind’.

Crucially, it is about working with people and not relying on an inflexible automated workflow system. 

With most translations being outsourced, the quality of the work can vary massively, often resulting in poor translations having to be corrected in-house, leading to additional costs and delays for the pharmaceutical company or CRO. If you therefore choose to work with a Language Service Provider (LSP) to manage this process, it is important to know exactly what is involved to ensure your translations are right first time.

Firstly, the ISO-recognised process comprises translation and then revision by a second independent linguist, with any disputed translations resolved by the LSP. Further optional steps include a second revision, in-country client review, and back translation, although the latter can double your costs without necessarily improving the quality of the original translation. There is also often the need for a review by an Ethics Committee (EC), which can remove some errors, but can introduce spelling or grammar errors too. Any EC or client changes should be sent back to the original translators to be checked again.

Further quality can be built into the process by using qualified translators with relevant medical expertise and using skilled linguists as project managers. Consistency can be improved by using the same translator for the whole project, although depending on the size of the documentation,this may sometimes be hard to implement, and translation memories will also help here (saving time and money too).

Finally, with complex project soften including 500–750 different documents, there should be a strong version control and tracked changes within the workflow system.

Dr Mark Hooper is a director at Conversis Medical. For more information visit conversis.com


10th March 2016

Share

Tags

Company Details

Conversis

+44 (0)1869255820

Contact Website

Address:
Bignell Park Barns
Chesterton
Bicester
Oxfordshire
OX26 1TD
United Kingdom

Latest content on this profile

Medical Translations: Why you need to get it right the first time
British and American senior medical executives admit to image and reputation being at risk because of misinterpreted cultural references or linguistic errors.
Conversis
Avoiding PR Disaster: Cultural Customisation

Conversis
10 tips on Transcreation
We have put together a few pointers that you should consider for the process of transcreation.
Conversis
Top 10 tips for Translation in Medical Communications
Accuracy and high-quality should be the most important decision factors when choosing your medical translations partner as there is no room for mistakes or ambiguities.
Conversis
How do you ensure your communication will excite and interest your patients
This is an opinion article on how to keep your patients interested and on board through the full clinical study
Conversis
What it takes to win at Cannes Health Lions
A podcast featuring our Director, Russell Goldsmith, talking with two judges of the Lions Health Awards, Zuleika Burnett, Executive Director for Creative and Innovation at Havas Life Medicom and Martin Hafley, Creative Director at DDB Remedy London, together with a past Bronze winner, Khalid Latiff, Associate Creative Director at Publicis Life Brands Resolute (PLBR), whose company also picked up a Silver and Bronze this year too.
Conversis